Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
78
VEON Quote, Financials, Valuation and Earnings
Last price:
$37.91
Seasonality move
:
1.15%
Day range:
$36.01 - $39.87
52-week range:
$18.50 - $39.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.69x
P/B ratio:
3.03x
Volume:
153.4K
Avg. volume:
62.5K
1-year change:
95.49%
Market cap:
$2.8B
Revenue:
$3.7B
EPS (TTM):
--
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.1B | $3.5B | $3.9B | $3.8B | $3.7B | |
| Revenue Growth (YoY) | -10.97% | -56.95% | 10.57% | -2.47% | -1.52% | |
| Cost of Revenues | $1.8B | $454M | $484M | $476M | $441M | |
| Gross Profit | $6.2B | $3B | $3.4B | $3.3B | $3.3B | |
| Gross Profit Margin | 77.23% | 86.96% | 87.43% | 87.32% | 88.08% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.5B | $1.4B | $1.5B | $1.5B | $1.6B | |
| Other Inc / (Exp) | -$202M | $6M | -$13M | $356M | $139M | |
| Operating Expenses | $4.2B | $2.1B | $2.3B | $2.3B | $2.4B | |
| Operating Income | $2.1B | $917M | $1.1B | $997M | $891M | |
| Net Interest Expenses | $824M | $550M | $578M | $551M | $471M | |
| EBT. Incl. Unusual Items | $1B | $373M | $464M | $802M | $559M | |
| Earnings of Discontinued Ops. | $101M | -$410M | $681M | -$742M | -$2.8B | |
| Income Tax Expense | $462M | $279M | $344M | $69M | $179M | |
| Net Income to Company | $1B | $373M | $464M | $802M | $559M | |
| Minority Interest in Earnings | -$62M | -$33M | -$127M | -$153M | -$78M | |
| Net Income to Common Excl Extra Items | $621M | -$349M | $674M | -$162M | -$2.5B | |
| Basic EPS (Cont. Ops) | $9.00 | -$5.00 | $9.50 | -$2.25 | -$36.00 | |
| Diluted EPS (Cont. Ops) | $9.00 | -$5.00 | $9.50 | -$2.25 | -$36.00 | |
| Weighted Average Basic Share | $70M | $70.1M | $70.2M | $70.2M | $70.2M | |
| Weighted Average Diluted Share | $70M | $70.4M | $71.3M | $71.3M | $71.3M | |
| EBITDA | $3.9B | $1.7B | $1.9B | $2.2B | $1.8B | |
| EBIT | $1.9B | $942M | $1.1B | $1.4B | $1.1B | |
| Revenue (Reported) | $8.1B | $3.5B | $3.9B | $3.8B | $3.7B | |
| Operating Income (Reported) | $2.1B | $917M | $1.1B | $997M | $891M | |
| Operating Income (Adjusted) | $1.9B | $942M | $1.1B | $1.4B | $1.1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $2B | -- | $945M | $1B | |
| Revenue Growth (YoY) | -18.21% | 10.23% | -- | -52.87% | 13.32% | |
| Cost of Revenues | $440M | $486M | -- | -- | -- | |
| Gross Profit | $1.4B | $1.5B | -- | -- | -- | |
| Gross Profit Margin | 75.81% | 75.76% | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $561M | $631M | -- | -- | -- | |
| Other Inc / (Exp) | -$788M | $2M | -- | -- | -- | |
| Operating Expenses | $987M | $1.1B | -- | -- | -- | |
| Operating Income | $392M | $417M | -- | -- | -- | |
| Net Interest Expenses | $169M | $181M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$565M | $238M | -- | -- | -- | |
| Earnings of Discontinued Ops. | $24M | $68M | -- | -- | -- | |
| Income Tax Expense | $103M | $111M | -- | -- | -- | |
| Net Income to Company | -$613M | $238M | -- | -- | -- | |
| Minority Interest in Earnings | $24M | -$50M | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$620M | $145M | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -$8.75 | $2.25 | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -$8.75 | $2.25 | -- | -- | -- | |
| Weighted Average Basic Share | $70.9M | $64.4M | -- | $70.2M | $70.7M | |
| Weighted Average Diluted Share | $70.9M | $64.4M | -- | $70.2M | $70.7M | |
| EBITDA | $738M | $896M | -- | -- | -- | |
| EBIT | -$391M | $424M | -- | -- | -- | |
| Revenue (Reported) | $1.8B | $2B | -- | $945M | $1B | |
| Operating Income (Reported) | $392M | $417M | -- | -- | -- | |
| Operating Income (Adjusted) | -$391M | $424M | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $7.3B | $3.9B | -- | $932M | $4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.7B | $616M | -- | -- | -- | |
| Gross Profit | $5.6B | $3.3B | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.2B | $1.5B | -- | -- | -- | |
| Other Inc / (Exp) | -$781M | $731M | -- | $37M | -$32M | |
| Operating Expenses | $4.1B | $2.3B | -- | -- | -- | |
| Operating Income | $1.4B | $998M | -- | -- | -- | |
| Net Interest Expenses | $743M | $509M | -- | $341M | $106M | |
| EBT. Incl. Unusual Items | -$78M | $1.2B | -- | -- | -- | |
| Earnings of Discontinued Ops. | $24M | -$393M | -- | $857M | -- | |
| Income Tax Expense | $348M | $332M | -- | -- | -- | |
| Net Income to Company | -$126M | $1.2B | -- | -- | -- | |
| Minority Interest in Earnings | -$33M | -$112M | -- | -$111M | -$21M | |
| Net Income to Common Excl Extra Items | -$334M | $382M | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -$4.69 | $5.50 | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -$4.69 | $5.50 | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $3.1B | $2.6B | -- | -- | -- | |
| EBIT | $693M | $1.7B | -- | -- | -- | |
| Revenue (Reported) | $7.3B | $3.9B | -- | $932M | $4B | |
| Operating Income (Reported) | $1.4B | $998M | -- | -- | -- | |
| Operating Income (Adjusted) | $693M | $1.7B | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5.8B | $5.9B | $957M | $1.9B | $2.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.3B | $1.4B | $120M | $110M | $121M | |
| Gross Profit | $4.5B | $4.5B | $837M | $806M | $906M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.9B | $1.9B | $373M | $391M | $446M | |
| Other Inc / (Exp) | -$721M | $8M | -$18M | $80M | -$32M | |
| Operating Expenses | $3.3B | $3.3B | $568M | $575M | $626M | |
| Operating Income | $1.1B | $1.2B | $269M | $231M | $280M | |
| Net Interest Expenses | $545M | $499M | $137M | $123M | $106M | |
| EBT. Incl. Unusual Items | -$127M | $671M | $114M | $188M | $142M | |
| Earnings of Discontinued Ops. | $24M | $76M | $141M | $123M | -- | |
| Income Tax Expense | $246M | $287M | $71M | $40M | $53M | |
| Net Income to Company | -$175M | $655M | -- | -- | -- | |
| Minority Interest in Earnings | -$7M | -$85M | -$48M | -$21M | -$21M | |
| Net Income to Common Excl Extra Items | -$356M | $375M | $136M | $250M | $68M | |
| Basic EPS (Cont. Ops) | -$5.00 | $5.50 | $2.00 | $3.50 | $1.00 | |
| Diluted EPS (Cont. Ops) | -$5.00 | $5.50 | $2.00 | $3.50 | $1.00 | |
| Weighted Average Basic Share | $212.2M | $205.4M | $68M | $141.7M | $138.7M | |
| Weighted Average Diluted Share | $212.2M | $205.4M | $68M | $141.7M | $138.7M | |
| EBITDA | $2.6B | $2.6B | $451M | $512M | $439M | |
| EBIT | $438M | $1.2B | $256M | $328M | $259M | |
| Revenue (Reported) | $5.8B | $5.9B | $957M | $1.9B | $2.1B | |
| Operating Income (Reported) | $1.1B | $1.2B | $269M | $231M | $280M | |
| Operating Income (Adjusted) | $438M | $1.2B | $256M | $328M | $259M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.3B | $1.7B | $2.3B | $3.1B | $1.9B | |
| Short Term Investments | $82M | $90M | $86M | $120M | $433M | |
| Accounts Receivable, Net | $610M | $544M | $679M | $446M | $412M | |
| Inventory | $169M | $111M | $111M | $18M | $23M | |
| Prepaid Expenses | $156M | $134M | $126M | $105M | $95M | |
| Other Current Assets | $40M | $42M | $58M | $54M | $60M | |
| Total Current Assets | $2.5B | $2.9B | $5.4B | $9.8B | $3.2B | |
| Property Plant And Equipment | $7.3B | $6.9B | $6.7B | $2.8B | $2.9B | |
| Long-Term Investments | $235M | $305M | $99M | $71M | $53M | |
| Goodwill | $4B | $2.7B | $1.5B | $394M | $349M | |
| Other Intangibles | $1.7B | $1.5B | $1.7B | $1.6B | $1.3B | |
| Other Long-Term Assets | $32M | $18M | $34M | $24M | $74M | |
| Total Assets | $16.1B | $14.6B | $15.9B | $15.1B | $8.2B | |
| Accounts Payable | $1.8B | $1.9B | $2B | $1.1B | $1.2B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $279M | $200M | $582M | $4.4B | $123M | |
| Total Current Liabilities | $5.8B | $4.4B | $4.8B | $8.9B | $3.6B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $13.8B | $13.5B | $14.4B | $14.3B | $7.1B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | |
| Other Common Equity Adj | -$1.9B | -$1.9B | -$2B | -$2B | -$2B | |
| Common Equity | $1.2B | $163M | $586M | $569M | $858M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $994M | $850M | $919M | $198M | $213M | |
| Total Equity | $2.2B | $1B | $1.5B | $767M | $1.1B | |
| Total Liabilities and Equity | $16.1B | $14.6B | $15.9B | $15.1B | $8.2B | |
| Cash and Short Terms | $1.3B | $1.8B | $2.3B | $3.2B | $2.3B | |
| Total Debt | $10.3B | $10.1B | $10.6B | $8.2B | $5.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $1.5B | -- | -- | -- | |
| Short Term Investments | $216M | $32M | -- | -- | -- | |
| Accounts Receivable, Net | $533M | $671M | -- | -- | -- | |
| Inventory | $98M | $112M | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $303M | $315M | -- | -- | -- | |
| Total Current Assets | $2.3B | $5B | -- | -- | -- | |
| Property Plant And Equipment | $6.2B | $6.4B | -- | -- | -- | |
| Long-Term Investments | $287M | $57M | -- | -- | -- | |
| Goodwill | $2.6B | $2.7B | -- | -- | -- | |
| Other Intangibles | $1.5B | $467M | -- | -- | -- | |
| Other Long-Term Assets | $165M | $200M | -- | -- | -- | |
| Total Assets | $13.1B | $15B | -- | -- | -- | |
| Accounts Payable | $1.7B | $1.9B | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $844M | $1.3B | -- | -- | -- | |
| Total Current Liabilities | $5B | $4.8B | -- | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $12.3B | $13.7B | -- | -- | -- | |
| Common Stock | $2M | $2M | -- | -- | -- | |
| Other Common Equity Adj | -$1.9B | -$2B | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $857M | $898M | -- | -- | -- | |
| Total Equity | $832M | $1.3B | -- | -- | -- | |
| Total Liabilities and Equity | $13.1B | $15B | -- | -- | -- | |
| Cash and Short Terms | $1.3B | $1.5B | -- | -- | -- | |
| Total Debt | $9.2B | $9.9B | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1B | $373M | $464M | $802M | $559M | |
| Depreciation & Amoritzation | $2B | $792M | $799M | $778M | $735M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$158M | -$18M | -$141M | -$154M | -$1M | |
| Change in Inventories | -$28M | -$5M | -$4M | -$12M | -$19M | |
| Cash From Operations | $2.9B | $2.4B | $2.6B | $2.6B | $2.1B | |
| Capital Expenditures | $1.6B | $682M | $858M | $1B | $766M | |
| Cash Acquisitions | -- | -$10M | -- | $24M | -- | |
| Cash From Investing | -$1.9B | -$1.9B | -$1.2B | -$1.7B | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | -$520M | -$259M | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.6B | $4.6B | $2.1B | $2.1B | $194M | |
| Long-Term Debt Repaid | -$2.9B | -$4.1B | -$2B | -$1.6B | -$1.1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$682M | -$40M | -$296M | -$12M | -$15M | |
| Cash From Financing | -$1.6B | -$103M | -$744M | $116M | -$1.1B | |
| Beginning Cash (CF) | $1.8B | $1.2B | $1.7B | $2.2B | $3.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$564M | $474M | $596M | $963M | -$1.2B | |
| Ending Cash (CF) | $1.2B | $1.7B | $2.2B | $3.1B | $1.9B | |
| Levered Free Cash Flow | $1.4B | $1.8B | $1.8B | $1.5B | $1.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$613M | $238M | -- | -- | -- | |
| Depreciation & Amoritzation | $1.1B | $472M | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $33M | -$60M | -- | -- | -- | |
| Change in Inventories | -- | $6M | -- | -- | -- | |
| Cash From Operations | $770M | $803M | -- | -- | -- | |
| Capital Expenditures | $316M | $346M | -- | -- | -- | |
| Cash Acquisitions | -- | $13M | -- | -- | -- | |
| Cash From Investing | -$354M | -$430M | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $261M | $398M | -- | -- | -- | |
| Long-Term Debt Repaid | -$805M | -$385M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$24M | -$12M | -- | -- | -- | |
| Cash From Financing | -$633M | -$49M | -- | -- | -- | |
| Beginning Cash (CF) | $1.2B | $1.2B | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -$22M | -$17M | -- | -- | -- | |
| Additions / Reductions | -$217M | $323M | -- | -- | -- | |
| Ending Cash (CF) | $989M | $1.5B | -- | -- | -- | |
| Levered Free Cash Flow | $454M | $457M | -- | -- | -- | |
| Period Ending | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1B | -$126M | $1.2B | -- | -- | |
| Depreciation & Amoritzation | $2.1B | $2.4B | $50M | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$208M | -$44M | -$121M | -- | -- | |
| Change in Inventories | $18M | $36M | -$58M | -- | -- | |
| Cash From Operations | $2.9B | $2.5B | $2.6B | -- | -- | |
| Capital Expenditures | $1.6B | $1.6B | $800M | -- | -$469M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.8B | -$1.9B | -$2B | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$541M | -$259M | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.9B | $3.9B | $2.2B | -- | -- | |
| Long-Term Debt Repaid | -$3.5B | -$4.3B | -$1.7B | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$739M | $12M | -$281M | -- | -- | |
| Cash From Financing | -$2.9B | -$865M | -$6M | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.8B | -$184M | $580M | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.3B | $944M | $1.8B | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$175M | $655M | -- | -- | -- | |
| Depreciation & Amoritzation | $2.1B | $1.4B | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$67M | -$170M | -- | -- | -- | |
| Change in Inventories | $45M | -$8M | -- | -- | -- | |
| Cash From Operations | $1.9B | $2B | -- | -- | -- | |
| Capital Expenditures | $1.2B | $1.3B | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.4B | -$1.5B | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$259M | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3.2B | $835M | -- | -- | -- | |
| Long-Term Debt Repaid | -$3.5B | -$1.1B | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$44M | -$285M | -- | -- | -- | |
| Cash From Financing | -$694M | -$597M | -- | -- | -- | |
| Beginning Cash (CF) | $3.8B | $3.9B | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -$59M | -$17M | -- | -- | -- | |
| Additions / Reductions | -$190M | -$84M | -- | -- | -- | |
| Ending Cash (CF) | $3.6B | $3.8B | -- | -- | -- | |
| Levered Free Cash Flow | $666M | $675M | -- | -- | -- | |
Get VEON Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VEON
Sector
P/E ratio
--
16.53x
PEG ratio
--
0.01x
P/B ratio
3.03x
1.42x
Price / LTM sales
0.69x
0.94x
Growth Metrics
VEON
Sector
Revenue growth
13.32%
-0.19%
Earnings growth
-50%
0.38%
Revenue (5-year growth)
-16.46%
1.77%
Earnings forecast
$0.57
$0.14
Profitability
VEON
Sector
Profitability FY 2023
$3.3B
$343.9M
Return on invested capital
--
0.93%
Return on assets
--
0.07%
Return on equity
--
2.61%
Earnings Date
Last Earnings Date
Nov
14
Next Earnings Date
Mar
21
Estimated Next Earnings Date
Feb
13
Balance Sheet
VEON
Sector
Total cash
$1.4B
$114.9M
Short term investments
$433M
$67.8M
Total assets
$8.2B
$1B
Long term debt
--
$54.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 0.73% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.55% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.65% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
